Omega Healthcare Investors (NYSE:OHI – Get Free Report) posted its earnings results on Tuesday. The real estate investment trust reported $0.27 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.20), FiscalAI reports. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The business had revenue of $340.55 million during the quarter, compared to analyst estimates of $269.16 million. During the same quarter in the prior year, the business earned $0.79 earnings per share. The firm’s revenue was down 3.0% compared to the same quarter last year.
Omega Healthcare Investors Price Performance
OHI traded up $0.64 on Wednesday, hitting $48.17. The company had a trading volume of 577,169 shares, compared to its average volume of 2,064,443. Omega Healthcare Investors has a 1-year low of $41.53 and a 1-year high of $52.39. The stock has a market cap of $14.60 billion, a price-to-earnings ratio of 17.19, a price-to-earnings-growth ratio of 1.90 and a beta of 0.56. The company’s fifty day moving average price is $46.18 and its 200 day moving average price is $46.63.
Omega Healthcare Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, November 5th will be paid a dividend of $0.68 per share. This represents a $2.72 annualized dividend and a dividend yield of 5.6%. The ex-dividend date is Thursday, November 5th. Omega Healthcare Investors’s dividend payout ratio is 97.14%.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on OHI. Wells Fargo & Company lowered their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Cantor Fitzgerald increased their price target on Omega Healthcare Investors from $52.00 to $56.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Citigroup upgraded Omega Healthcare Investors from a “buy” rating to an “outperform” rating in a research report on Thursday, October 22nd. Barclays dropped their price objective on Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating on the stock in a research note on Tuesday, October 13th. Finally, Wall Street Zen upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $49.93.
Get Our Latest Stock Analysis on OHI
More Omega Healthcare Investors News
Here are the key news stories impacting Omega Healthcare Investors this week:
- Positive Sentiment: Third-quarter FFO was $0.82 per share, above the $0.81 consensus and up from $0.79 a year earlier. AFFO and revenue also rose, according to reports on the quarter. Article: Omega Healthcare Investors Surpasses Q3 FFO and Revenue Estimates
- Positive Sentiment: OHI lifted its 2026 adjusted FFO-per-share forecast to $3.28–$3.30, above the prior outlook and the cited FactSet estimate of $3.26. Reduced leverage and stronger funds available for distribution add support to the outlook. Article: Omega Healthcare Investors Q3 AFFO, Revenue Rise; Lifts 2026 Guidance
- Neutral Sentiment: Analysts’ consensus target price is $49.93, offering a reference point for expectations but not a guarantee of future performance. Article: OHI Stock Has Consensus Target Price of $49.93 According to Analysts
- Negative Sentiment: Reported GAAP EPS of $0.27 missed the $0.47 consensus, while quarterly revenue was down 3% year over year. Those results may offset some of the stronger FFO and guidance news. Article: Omega Healthcare Investors Reports Third-Quarter Results
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.
Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.
Further Reading
- Five stocks we like better than Omega Healthcare Investors
- Advanced Micro Devices’ Q3 Results Answer a Big Question, But Another Remains
- High Voltage Returns: Talen Energy Powers the Data Center Rush
- 3 Dividend Increases Above 10%, But Which Offers the Most Income?
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
